# ContinuumOS Project Status

## Last updated

2026-07-24

## Current position

### Current status — supersedes the historical Sprint 3-start bullets below

- Sprint 4 final traceability review against Sprints 1–3 is complete with no unresolved material gap.
- Active sprint: Sprint 5 — Requirements Baseline and Solution Definition.
- Overall status: Sprint 1–3 documentation and dependency alignment are complete; Sprint 3 scope, user/decision model, integration assumptions and MVP boundary are frozen for downstream work.
- Current focus: complete the remaining Sprint 5 Part 2 operating controls after finishing one-to-one structured traceability for the 56-entry requirements register; prototype build has not started.

- Sprint 2 canonical dependency alignment cleanup is complete; Sprint 3 is ready to begin.
- Active sprint: Sprint 3 — Users, Decisions and MVP
- Overall status: Sprint 2 documentation and canonical dependency alignment complete; business-value framing added; project ready for Sprint 3
- Current focus: Sprint 3 steps 1–2 complete; define jobs-to-be-done and acceptance conditions next

## Sprint status

| Sprint | Scope | Status |
|---|---|---|
| Sprint 1 | Product Case | Complete |
| Sprint 2 | Care Journey and Operating Model | Complete |
| Sprint 3 | Users, Decisions and MVP | Complete |
| Sprint 4 | Architecture and AI Operating Model | Complete |
| Sprint 5 | Requirements Baseline and Solution Definition | In progress — Part 1 complete |
| Sprint 6 | Prototype Build, Testing and Controlled Release | Not started |
| Sprint 7 | External Validation, Synthetic Pilot and Portfolio Packaging | Not started |

## Completed setup

- Seven sprint folders created.
- Seven sprint tracker files created.
- `AGENTS.md`, `CODEX.md`, `PROJECT_RULES.md` and `VOICE.md` are present.
- Project-local prototype design standards are now documented in `design skills/`; they are guidance only and have not yet been applied to prototype code.
- Sprint 1 product-case content, scope, workflow, state model, registers and Product Case Charter are documented.
- No prototype code, user research, clinical validation, implementation evidence or outcome claims have been completed.
- Sprint 5–7 plan structure was added on 2026-07-18. It is a controlled plan and template set only: no requirements have been approved, no prototype has been built, no tests or AI evaluations have been executed, and no reviewer or pilot evidence has been recorded.

## Current blockers

- None recorded.

## Latest completed work

- Ten-screen Sprint 5 specification alignment correction completed on 2026-07-24. `screen_specifications_and_wireframe_pack.md` and `state_to_screen_navigation_map.csv` now use the canonical Asha synthetic fixture identifiers and distinguish RTM-primary requirements, supporting controls and atomic acceptance references. Role-specific actions, T08 clinic-management completion, T09 referral creation, T11 referral confirmation, T14 scoped closure, SCR-08 return routes, safe exception recovery and disabled incomplete-evidence actions are aligned across SCR-01 to SCR-10. This was an internal specification review only; no prototype, test, user review, integration, model capability or approval claim was added. The next work remains the cross-screen data dictionary and detailed business-rule/validation catalogue.

- Sprint 5 Part 2C screen-specification work completed on 2026-07-24. `screen_specifications_and_wireframe_pack.md` now covers all ten planned screens. SCR-07 keeps exceptions visible, owned and safely recoverable; SCR-08 treats AI as an optional source-linked draft with explicit human review and manual fallback; SCR-09 provides append-oriented audit/trace visibility; SCR-10 separates Next Step Confirmed from scoped diagnostic-closure workflow completion. The Asha journey rail remains supporting synthetic context only. No prototype, integration, model capability, test, user review or outcome claim was added. The remaining Sprint 5 Part 2 work is to complete cross-screen data-field and detailed rule/validation controls before Part 3 readiness review.

- Sprint 5 Part 2B screen-specification work completed on 2026-07-24. `screen_specifications_and_wireframe_pack.md` now defines planned behaviour, traceability, source fields, authorised actions, validation, failure routes, audit evidence and low-fidelity wireframes for SCR-04 human follow-up direction, SCR-05 referral handoff preparation/routing and SCR-06 receiving response. The specifications preserve the human control chain: Clinic physician selects the direction, Referral Coordinator prepares/routes an approved package, and the receiving team alone accepts or rejects it. A rejected referral returns work to the Clinic physician without automatic redirection. The Asha journey rail remains supporting visual context only. No prototype, integration, AI capability, test, user review or outcome claim was added.

- Sprint 5 Part 2A screen-specification work completed on 2026-07-23. `screen_specifications_and_wireframe_pack.md` now defines planned behaviour, traceability, source fields, authorised actions, validation, failure routes, audit evidence and low-fidelity wireframes for SCR-01 simulated SMART launch, SCR-02 episode workspace and SCR-03 result review/acknowledgement. The approved synthetic Asha Mehta tracer is carried through these screens via a compact, non-photorealistic journey rail; it adds no workflow state, role, source data, ambient-transcription function or AI capability. The pack remains pre-development documentation only. The data dictionary and detailed rule/validation catalogue remain to be completed before Part 3 prototype approval.

- Sprint 5 requirements-register traceability control completed on 2026-07-18. All 56 entries in `consolidated_requirements_register.csv` now have exactly one structured record in `requirements_traceability_matrix.csv`, covering parent business requirement, source artifact/ID, state/transition, decision/capability, planned screen, event, data-contract reference, acceptance ID, prototype scenario and planned UAT ID. FR-23, FR-26 and FR-28 remain consistently deferred; no requirement is approved for prototype. Screen and UAT identifiers are planning references only and do not claim a built screen or executed test. Part 2 RACI, RAID, rule/validation and data-field controls remain pending.

- Sprint 5 RTM format enhancement completed on 2026-07-18. The RTM now combines its source-to-test traceability with controlled delivery metadata: parent requirement, level/title/description, owner, author, priority, business impact, target release, related user story, acceptance reference, planned test phase, defect placeholder, sign-off owner, lifecycle dates and comments. Deferred items explicitly state `Roadmap — no Sprint 6 test`; no result, defect, sign-off or test-execution claim was added.

- Ten planned screen IDs (`SCR-01` to `SCR-10`) are now resolved in `state_to_screen_navigation_map.csv`, covering launch, workspace, result review, direction, handoff, receiving response, exceptions, AI review, audit and confirmation/closure. Each records authorised actors, permitted actions, resulting state, success/failure route and event references. All remain `Planned`; no prototype screen or navigation behaviour is claimed as built.

- Sprint 5 senior-product/Lead-BA framing enhancement completed on 2026-07-18. The BRD now records the problem-evidence boundary, why diagnostic closure was selected, why deterministic controls and the two narrow AI assists were chosen, why financial/detail exceptions and preventive health checks were deferred, and how targets can be set only after synthetic evidence exists. Six decision-relevant measures now have calculation, baseline status, target approach and evidence classification. The prototype-scenario plan now requires a complete Asha journey, critical exception, amended-result re-review, both AI review/failure demonstrations, downstream evaluation inputs and delivery/reflection evidence. These are plans and validation obligations only; no prototype, test, reviewer, pilot, model-performance or outcome evidence is claimed.

- Sprint 5 Part 1 baseline-quality correction completed on 2026-07-18: MVP scope was tightened by deferring financial readiness/denial and detailed cancellation/no-show requirements to the roadmap; next-step confirmation and scoped workflow closure were separated; result availability/version integrity and audit correction/recovery were made independently testable; and six NFRs were added for accessibility, least-privilege role visibility, understandable errors, audit completeness, high-risk action confirmation and prototype responsiveness. An acceptance-criteria catalogue now provides atomic checks for all 33 functional and 9 non-functional requirements. `Reviewed` now means internal source-alignment review only; no requirement is approved for prototype. A Phase 2 preventive-health-check orchestration entry was added to the BRD roadmap only, with no MVP requirements. Canonical `Referral Pending` wording was removed in favour of `Referral Created`. No prototype, testing, user research, clinical validation, live integration, model call or outcome claim was added.

- Sprint 5 Part 1 completed and corrected on 2026-07-18: delivery sequence and source authority were recorded, the BRD-lite was enhanced from the approved Sprint 1–4 baseline, and the reviewed requirement baseline was expanded from 25 to 46 entries. The correction adds explicit coverage for episode initiation, diagnostic acceptance/scheduling/completion, clinician-review and follow-up-task assignment, clinic-management, financial-dependency, communication, amendment/reassessment, named operational exceptions, referral rejection and financial-denial recovery, plus eight stakeholder user stories. The BRD now explicitly covers the AI rationale and limits, target state, scope, phased delivery, AI objectives/measurement boundary, synthetic data/governance boundary, human review/explainability, stakeholder impact and constraints. All entries remain `Reviewed`; approval for the Sprint 6 clickable prototype is reserved for the Part 3 end-to-end baseline review. No prototype, testing, user research, clinical validation, live integration, model call or outcome claim was added.

- Sprint 4 final traceability review against Sprints 1–3 completed on 2026-07-18. `final_traceability_review_against_sprints_1_to_3.md` verifies canonical states/transitions, source authority, linkage, human decision rights, synthetic FHIR/Task/SMART boundaries, event/recovery semantics, the two-capability AI boundary, audit/analytics controls and HIE/roadmap language across every Sprint 4 artifact. Four bounded corrections aligned EVT-22/audit communication-confirmation wording to T14/D17, strengthened EVT-04 event linkage, mapped EVT-06 subtypes to T01/T02/T03 and removed stale references to already-created Sprint 4 contracts. Seven governing CSVs, 11 JSON fixture blocks, all 22 EVT IDs/names, required transition references and two Mermaid artifacts passed structural validation. No unresolved material traceability gap, new scope, implementation claim or production-readiness claim remains; Sprint 4 stays Complete as requirements-level documentation.

- Sprint 4 Parts 7–8 completed on 2026-07-18: an illustrative regional HIE deployment-readiness checklist and a technical decisions/roadmap-label register are documented. The HIE checklist is explicitly not assessed and grants no deployment approval; roadmap labels distinguish the synthetic MVP from represent-only, future-readiness and deferred/excluded work. Sprint 4 is now documentation complete. No participant, legal, consent, security, conformance, integration or deployment claim was added.

- Sprint 4 HIE and roadmap precision correction completed on 2026-07-18. The checklist now covers multi-organisation exchange applicability, data residency, terminology mapping governance and participant exit; the roadmap separates design-only, represent-only and future-readiness decisions and records multi-entry audit history and source-version reassessment controls. No readiness, pilot or deployment claim was added.

- Sprint 4 Parts 5–6 completed on 2026-07-18: the two approved AI service cards/control matrix and the audit-and-analytics data contract are documented. AI remains optional, source-linked and human-reviewed; audit history is append-oriented target behaviour; derived measures are explicitly read-only and cannot trigger workflow, AI, communication or decisions. No model deployment, metric result, dashboard, production audit platform or outcome claim was added.

- Sprint 4 AI and audit/analytics precision correction completed on 2026-07-18. AI stale-output, reviewer disposition, unsupported-content and storage rules now align with EVT-20; event names are primary metric dependencies; audit timestamps, actor types, multi-entry event history and metric data-quality/version fields are explicit. No implementation, model evaluation result, dashboard or operational outcome claim was added.

- Sprint 4 SMART and synthetic-fixture precision correction completed on 2026-07-18. The clinician launch sequence now models SMART discovery, authorisation and authorised FHIR retrieval; user-context Practitioner access and separate reporting/ordering roles are explicit. The T04 completion test is consistently labelled as an approved synthetic-fixture rule rather than a universal FHIR constraint, with amended-report and separate source-completion fixtures added. No live OAuth, production FHIR conformance, source write-back or clinical claim was added.

- Sprint 4 Part 3 and Part 4 completed on 2026-07-18: the clinician-only SMART on FHIR launch sequence and the event catalogue with semantic idempotency, explicit decision/assignment/referral/confirmation/closure event contracts, duplicate handling and safe recovery rules are documented. The synthetic FHIR resource fixture definition remains a supporting data-boundary artifact rather than the agreed Part 4 deliverable. No live integration, source write-back, production conformance, production security, clinical validation or outcome claim was added.

- Sprint 4 version-change and decision-register verification completed on 2026-07-18. Amended and corrected report versions are now explicit in E05/E06: they preserve prior acknowledgement as historical evidence only, require renewed review/acknowledgement and flag affected downstream direction, handoff and communication for human reassessment. D13–D18 were verified as non-conflicting clarifications of earlier decisions; their owners, rationale, relationships, affected artifacts and propagation status are recorded in the Sprint 4 decision clarification log. No MVP scope, state, authority or implementation claim changed.

- Sprint 4 parts 1–2 alignment correction completed on 2026-07-18. The governing architecture and derived diagram now align on SMART versus operations access, visible human actions, exception/safe return, optional AI fallback, complete-result evidence, minimum-necessary data, linkage contract, communication/confirmation separation, minimum closure evidence and append-oriented linked audit corrections. Decision Register D13–D18 and the required Sprint 1–3 dependency artifacts were synchronised. UAT and prototype artifacts do not yet exist; their carry-forward controls are recorded for later work. No scope, state, authority, implementation or outcome claim was added.

- Sprint 4 parts 1–2 completed on 2026-07-18: the architecture principles/boundary and simplified logical architecture diagram are documented. The design preserves source-system authority, the canonical workflow and human gates, the six-source-FHIR-plus-internal-Task boundary, deterministic versus AI separation, exception-first recovery and explicit MVP/represent-only/future labels. The Sprint 4 tracker was corrected so missing-handoff detection remains deterministic and the two approved AI capabilities remain the source-linked episode summary and post-approval referral-handoff draft. No implementation or production-readiness claim was added.

- Sprint 2 Sections 5–8 documented: decision rights, system-of-record boundary, failure-path map, and Sprint 1 register reconciliation.
- Added `decision_rights_matrix.csv`, `system_of_record_table.csv`, `failure_path_map.md` and `sprint_2_review_and_exit_checklist.md` under the Sprint 2 folder.
- Product-owner acceptance recorded on 2026-07-16; Sprint 2 marked complete as a documented package.
- Review cleanup completed: CSV quoting and alignment repaired, ambiguous accountability split, and four additional data/write failure cases added.
- Sprint 2 issue corrections completed: the detailed Mermaid node collision was repaired; referral acceptance, financial-authorisation and DR13 roles were standardized; the current-state failure summary was added; outdated wording, AI-boundary wording, result-never-arrives handling and financial-branch labels were clarified; and internal portfolio self-review wording was qualified.
- No prototype, architecture implementation, real integration, user research, clinical validation or outcome claim was added.
- Canonical dependency alignment completed before Sprint 3: authority hierarchy, canonical AI scope, role vocabulary, referral and financial accountability, urgent-escalation policy D12, superseded Sprint 1 wording and repeated-registration terminology were aligned across Sprint 1 and Sprint 2.
- Business-value hypothesis and external-learning rationale added on 2026-07-18. Existing metrics were mapped to workflow timeliness, ownership, handoff quality and coordination value; presentation wording was simplified for interviewer clarity. No scope, state, human-control or AI-boundary change was made.
- Sprint 3 steps 1–2 completed on 2026-07-18: inherited baseline and canonical vocabulary frozen in `sprint_3_baseline_and_alignment.md`; stakeholder map created from approved Sprint 1/Sprint 2 roles and ownership. No scope, state, human-control or AI-boundary change was made.

## Planned-control update

- On 2026-07-19, Sprint 5 planning scope was extended to include a product roadmap, MoSCoW plus impact-versus-effort matrix, stakeholder-engagement plan, project-governance plan/control calendar and AI approach decision record. Sprint 6 will plan to apply project controls to baseline changes and release decisions; Sprint 7 will plan to trace reviewer evidence to roadmap and governance updates. Project governance is explicitly distinct from clinical, data, AI and operational governance. No newly planned artifact has been populated, executed, approved or validated.

- On 2026-07-19, the planned BA control set was added without execution claims: qualitative MoSCoW/value-impact-effort/delay/dependency prioritisation; Definition of Ready/Done; open-question resolution logging; a four-diagram process/system/data/state pack; UAT readiness/sign-off and synthetic data-reconciliation trackers; and a Sprint 7 evidence scorecard. The existing Sprint 1 `success_metrics.md` was confirmed as the authoritative success-measure framework; no duplicate metrics were created and no targets/results were added.

- On 2026-07-19, Sprint 5 planning was extended with a required screen-specification and low-fidelity wireframe pack for `SCR-01` to `SCR-10`. It must cover requirements, roles, fields/source, actions, validation, empty/loading/error/exception states, navigation/state outcome and audit evidence before Part 3 prototype approval. Sprint 6 may build only from that approved specification or an approved change record. No wireframe or prototype screen has been created.

- On 2026-07-19, Sprint 5 delivery controls were completed as planning artifacts: RACI and RAID were populated with planned roles, risks, assumptions and dependencies; the priority matrix now includes urgency and P1/P2/P3; the stakeholder plan includes power-interest engagement; and epic/story estimation, SLA/OLA/KPI operating, Unit/SIT/UAT and defect-triage methods were documented for downstream use. No estimates, tests, defects, SLAs, KPI results, stakeholder approvals, release decision or budget figure has been executed or claimed.

## Open decisions

- Sprint 3 final cross-artifact alignment review completed on 2026-07-18. Sprint 3 artifacts were checked against the Sprint 1 transition table, decision register and tracer, plus Sprint 2 decision-rights, system-of-record, failure-path and exit-checklist sources. The FHIR map now distinguishes six source FHIR R4 resources from the internal/simulated Task model, and the CAP-09 audit wording now states target behaviour rather than achieved implementation. CSV structure, unique IDs, job/capability references, canonical-state coverage, read-only candidate SMART scopes and raw-token restrictions were validated. Sprint 3 is documentation complete and ready for Sprint 4; no implementation, research, clinical validation, production readiness or outcome claim was added.

- Sprint 3 FHIR-map review correction completed: the demonstration is explicitly conceptual FHIR R4; ServiceRequest supports order evidence only; acceptance and scheduling require operational evidence; DiagnosticReport version/status semantics, `basedOn`, Observation traceability and the internal non-conformant Task boundary are explicit. No scope expansion or implementation claim was added.
- Sprint 3 field-map review correction completed: ServiceRequest status cannot create Order Accepted; Diagnostic Completed is sourced from an operational completion event; report version/status/re-review semantics and conditional Observation structures are explicit; FM-14 links DiagnosticReport.basedOn to the source order. No scope expansion or implementation claim was added.
- Sprint 3 permissions/interoperability review correction completed: omitted stakeholder access is explicit; the boundary is six source FHIR R4 types plus one internal task model; reconciliation decision and recording attribution are separated; patient/caregiver participation is represent-only; and candidate read-only SMART scopes are documented for Sprint 3. No scope expansion or implementation claim was added.

- Sprint 3 steps 7–8 completed: minimum FHIR resources and field mappings were defined; least-privilege permissions and SMART/FHIR, EHR-overlay, HL7 v2, workflow-state and timing assumptions were recorded. No production security, live integration or source-write implementation is claimed.

- Sprint 3 scope clarification completed: CAP-08 exception coordination is distinct from CAP-11 deterministic missing-handoff/exception detection; SMART on FHIR is a build-now synthetic launch demonstration while live EHR integration remains deferred; handoff readiness is separated from receiving acceptance; and `Episode Completed` is explicitly scoped to diagnostic-closure workflow completion.
- Sprint 3 integration-flow refinement completed: SMART authorisation and endpoint failures now stop protected retrieval without retaining credentials; Task is explicitly internal/simulated unless a separate FHIR write demonstration is approved; handoff roles are separated; and audit immutability is a target requirement rather than an implementation claim.

- Sprint 3 steps 5–6 completed: MVP scope and deferred capabilities were frozen, and the limited SMART-on-FHIR launch-to-audit integration flow was documented with source authority, human gates, deterministic controls and recovery rules. No live integration or implementation claim was added.

- Sprint 3 requirements correction completed: core, dependency and contextual jobs are now distinguished; deterministic missing-handoff/exception detection and post-approval AI referral-handoff drafting are explicit capabilities; the urgent financial branch traces to D12/T11U; and audit recording ownership is separated from user actions, platform integrity monitoring and governance review.

- Sprint 3 stakeholder-map authority reconciliation completed: the five authority roles are now explicit, report authorship is separated from diagnostic operations, receiving-team acceptance is distinct from specialist review, financial and payer work is limited to represent-only dependencies, and closure evidence is explicitly human-owned. The overall Sprint 3 completion checkbox remains open.
- Sprint 3 steps 3–4 completed on 2026-07-18: jobs-to-be-done and acceptance conditions were mapped for the required stakeholders and MVP capabilities; the decision-rights and AI-suitability matrix was added with explicit human owners, permitted assistive support, prohibited actions and failure handling. No implementation, user research, clinical validation or outcome claim was added.

- Confirm the final presentation scorecard.
- Confirm whether the existing Day 1 placeholder files remain the working location or should be consolidated under Sprint 1.
- Sprint 3 must carry forward unresolved assumptions A01/A02/A03/A08/A09/A10/A11, pilot hypotheses A05/A07/A12 and represent-only outage/write-failure behaviour.

## Update rule

Update this file when the active sprint, task status, decision, risk, blocker or completion evidence changes. Keep claims factual and distinguish planned work from completed work.
